Advertisement
Table 2 Leishmania spp. Antibiogram of ATCC© and Clinical Isolates Resistant at Varying Concentrations of Amphotericin B and Fluconazole
| Species | Total Number of Isolates | Amphotericin B (μg/mL) | Fluconazole (μg/mL) | |||
|---|---|---|---|---|---|---|
| 0.12 | 0.25 | 0.5 | 1 | ≥256 | ||
| Old World | ||||||
| L. donovani ATCC®50212™ | 3 | 3 (100%) | 0 (0%) | 0 (0%) | 0 (0%) | 3 (100%) |
| L. infantum ATCC®50134™ | 5 | 2 (40%) | 1 (20%) | 0 (0%) | 0 (0%) | 5 (100%) |
| Clinical L. infantum | 3 | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 3 (100%) |
| L. tropica ATCC®50129™ | 3 | 3 (100%) | 0 (0%) | 0 (0%) | 0 (0%) | 3 (100%) |
| Clinical L. tropica | 6 | 6 (100%) | 0 (0%) | 0 (0%) | 0 (0%) | 6 (100%) |
| L. major ATCC®50122™ | 4 | 4 (100%) | 3 (75%) | 0 (0%) | 0 (0%) | 4 (100%) |
| New World | ||||||
| L. amazonensis ATCC®50159™ | 3 | 3 (100%) | 2 (66.6%) | 1 (33.3%) | 0 (0%) | 3 (100%) |
| L. chagasi ATCC®50133™ | 3 | 3 (100%) | 1 (33.3%) | 0 (0%) | 0 (0%) | 3 (100%) |
| L. mexicana ATCC®50157™ | 3 | 3 (100%) | 1 (33.3%) | 0 (0%) | 0 (0%) | 3 (100%) |
| L. V. braziliensis ATCC® 50135™ | 3 | 3 (100%) | 0 (0%) | 0 (0%) | 0 (0%) | 3 (100%) |
| Clinical L. V. braziliensis | 3 | 3 (100%) | 3 (100%) | 0 (0%) | 0 (0%) | 3 (100%) |
| L. V. guyanensis ATCC®50126™ | 4 | 2 (50%) | 1 (25%) | 0 (0%) | 0 (0%) | 4 (100%) |
| L. V. panamensis ATCC®50158™ | 3 | 3 (100%) | 3 (100%) | 0 (0%) | 0 (0%) | 3 (100%) |
| Clinical L. V. panamensis | 15 | 4 (27%) | 3 (25%) | 1 (8.3%) | 0 (0%) | 15 (100%) |
